Maarten Hoek

2.2k total citations
27 papers, 1.2k citations indexed

About

Maarten Hoek is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Maarten Hoek has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Nephrology and 6 papers in Epidemiology. Recurrent topics in Maarten Hoek's work include Renal Diseases and Glomerulopathies (11 papers), Trypanosoma species research and implications (6 papers) and Biochemical and Molecular Research (5 papers). Maarten Hoek is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Trypanosoma species research and implications (6 papers) and Biochemical and Molecular Research (5 papers). Maarten Hoek collaborates with scholars based in United States, Netherlands and Germany. Maarten Hoek's co-authors include Bruce Stillman, George Cross, Jurrit Zeilstra, Giorgio Stassi, Huseyin Mehmet, Jan Paul Medema, Louis Vermeulen, Martin R. Sprick, Steven T. Pals and Alessandro Scopelliti and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Maarten Hoek

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maarten Hoek United States 18 718 253 248 210 145 27 1.2k
Lacramioara Ivanciu United States 17 456 0.6× 186 0.7× 150 0.6× 37 0.2× 35 0.2× 31 1.3k
R. E. Schmidt Germany 18 388 0.5× 231 0.9× 179 0.7× 54 0.3× 40 0.3× 40 1.4k
Simran Khurana United States 13 570 0.8× 114 0.5× 121 0.5× 60 0.3× 17 0.1× 18 797
William E. Munger United States 14 485 0.7× 218 0.9× 90 0.4× 49 0.2× 40 0.3× 20 1.0k
Oliver Gorka Germany 13 472 0.7× 81 0.3× 73 0.3× 50 0.2× 41 0.3× 24 873
Corinne Hiéblot France 18 496 0.7× 117 0.5× 110 0.4× 30 0.1× 33 0.2× 25 1.1k
Shinichiro Yoshida Japan 16 218 0.3× 208 0.8× 70 0.3× 18 0.1× 27 0.2× 65 1.2k
Lucía Cabal‐Hierro United States 10 316 0.4× 172 0.7× 107 0.4× 19 0.1× 43 0.3× 16 796
Fiona C. Kimberley Netherlands 11 583 0.8× 125 0.5× 67 0.3× 39 0.2× 39 0.3× 13 924
Alison A. Bertuch United States 27 1.4k 2.0× 209 0.8× 101 0.4× 7 0.0× 81 0.6× 77 2.2k

Countries citing papers authored by Maarten Hoek

Since Specialization
Citations

This map shows the geographic impact of Maarten Hoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Hoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Hoek more than expected).

Fields of papers citing papers by Maarten Hoek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Hoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Hoek. The network helps show where Maarten Hoek may publish in the future.

Co-authorship network of co-authors of Maarten Hoek

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Hoek. A scholar is included among the top collaborators of Maarten Hoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Hoek. Maarten Hoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garg, Ankur, Ayush Midha, Ryan A. Dick, et al.. (2025). HypoxyStat, a small-molecule form of hypoxia therapy that increases oxygen-hemoglobin affinity. Cell. 188(6). 1580–1588.e11. 5 indexed citations
2.
Limb, Susan L., Victoria A. Assimon, Janet M. Leeds, et al.. (2024). A Phase 1 Study in Healthy Adults of the Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, for the Treatment of APOL1-Mediated Kidney Disease (AMKD). Journal of the American Society of Nephrology. 35(10S).
3.
Hung, Adriana M., Victoria A. Assimon, Hua‐Chang Chen, et al.. (2022). Genetic Inhibition of APOL1 Pore Forming Function Prevents APOL1 Kidney Disease. Journal of the American Society of Nephrology. 33(11S). 411–411.
4.
Assimon, Victoria A., Sarah M. Bronner, Maarten Hoek, et al.. (2022). MZ-301 Is a Small Molecule Inhibitor of APOL1 Pore Function That Attenuates Albuminuria in a Mouse Model of APOL1-Mediated Kidney Disease. Journal of the American Society of Nephrology. 33(11S). 411–412. 1 indexed citations
5.
Hu, Lufei, Yinhong Chen, Xiaoyan Zhou, et al.. (2022). Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy. PLoS ONE. 17(1). e0261000–e0261000. 9 indexed citations
6.
Ge, Mengyuan, Judith Molina, Gloria Michelle Ducasa, et al.. (2021). APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis. Human Molecular Genetics. 30(3-4). 182–197. 33 indexed citations
7.
Wu, Zhenzhen, Sethu M. Madhavan, Michelle Chen, et al.. (2021). Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys. PLoS ONE. 16(6). e0253197–e0253197. 4 indexed citations
8.
Wakashin, Hidefumi, Jurgen Heymann, Hila Roshanravan, et al.. (2020). APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress. BMC Nephrology. 21(1). 371–371. 28 indexed citations
9.
Pallangyo, Pédrö, Mazen Albaghdadi, Peter Kisenge, et al.. (2020). PREVALENCE, PATTERNS AND PREDICTORS OF OBSTRUCTIVE CORONARY ARTERY DISEASE AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY IN A TERTIARY HOSPITAL IN TANZANIA. Journal of the American College of Cardiology. 75(11). 208–208. 2 indexed citations
10.
Ryu, Jung‐Hwa, Mengyuan Ge, Sandra Merscher, et al.. (2019). APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice. PLoS ONE. 14(4). e0211559–e0211559. 43 indexed citations
11.
Zhou, Xiaoyan, Eric S. Muise, Iyassu K. Sebhat, et al.. (2019). PAN-AMPK Activation Improves Renal Function in a Rat Model of Progressive Diabetic Nephropathy. Journal of Pharmacology and Experimental Therapeutics. 371(1). 45–55. 19 indexed citations
12.
Zhou, Xiaoyan, Wei Zhu, Rosemary Mayer‐Ezell, et al.. (2017). An integrin antagonist (MK‐0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model. Pharmacology Research & Perspectives. 5(5). 36 indexed citations
13.
Hoek, Maarten, Michael P. Myers, & Bruce Stillman. (2011). An Analysis of CAF-1-interacting Proteins Reveals Dynamic and Direct Interactions with the KU Complex and 14-3-3 Proteins. Journal of Biological Chemistry. 286(12). 10876–10887. 22 indexed citations
14.
Kemper, Kristel, Martin R. Sprick, Alessandro Scopelliti, et al.. (2010). The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation. Cancer Research. 70(2). 719–729. 288 indexed citations
15.
Hoek, Maarten, et al.. (2002). Trypanosoma brucei expression-site-associated-gene-8 protein interacts with a Pumilio family protein. Molecular and Biochemical Parasitology. 120(2). 269–283. 30 indexed citations
16.
Hoek, Maarten & George Cross. (2001). Expression-site-associated-gene-8 (ESAG8) is not required for regulation of the VSG expression site in Trypanosoma brucei. Molecular and Biochemical Parasitology. 117(2). 211–215. 9 indexed citations
17.
Zeng, Changjiang, Natalay Kouprina, Baoli Zhu, et al.. (2001). Large-Insert BAC/YAC Libraries for Selective Re-isolation of Genomic Regions by Homologous Recombination in Yeast. Genomics. 77(1-2). 27–34. 38 indexed citations
18.
Hoek, Maarten, et al.. (1999). Trypanosoma brucei:Generation of Specific Antisera to Recombinant Variant Surface Glycoproteins. Experimental Parasitology. 91(2). 199–202. 6 indexed citations
19.
Hoek, Maarten, et al.. (1998). Regulated processive transcription of chromatin by T7 RNA polymerase in Trypanosoma brucei. Nucleic Acids Research. 26(20). 4626–4634. 110 indexed citations
20.
Cross, Frederick R., Maarten Hoek, John D. McKinney, & Arthur H. Tinkelenberg. (1994). Role of Swi4 in Cell Cycle Regulation of CLN2 Expression. Molecular and Cellular Biology. 14(7). 4779–4787. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lacramioara Ivanciu Breakdown of academic impact, for papers by R. E. Schmidt Breakdown of academic impact, for papers by Simran Khurana Breakdown of academic impact, for papers by William E. Munger Breakdown of academic impact, for papers by Oliver Gorka Breakdown of academic impact, for papers by Corinne Hiéblot Breakdown of academic impact, for papers by Shinichiro Yoshida Breakdown of academic impact, for papers by Lucía Cabal‐Hierro Breakdown of academic impact, for papers by Fiona C. Kimberley Breakdown of academic impact, for papers by Alison A. Bertuch
Rankless by CCL
2026